These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3593438)

  • 1. Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis.
    Miller DR; Fiechtner JJ; Carpenter JR; Brown RR; Stroshane RM; Stecher VJ
    Arthritis Rheum; 1987 May; 30(5):567-71. PubMed ID: 3593438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
    Munster T; Gibbs JP; Shen D; Baethge BA; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; Lindsley H; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D; Furst DE
    Arthritis Rheum; 2002 Jun; 46(6):1460-9. PubMed ID: 12115175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.
    Am J Med; 1995 Feb; 98(2):156-68. PubMed ID: 7847432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine.
    Clegg DO; Dietz F; Duffy J; Willkens RF; Hurd E; Germain BF; Wall B; Wallace DJ; Bell CL; Sleckman J
    J Rheumatol; 1997 Oct; 24(10):1896-902. PubMed ID: 9330929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine in the treatment of rheumatoid arthritis.
    Adams EM; Yocum DE; Bell CL
    Am J Med; 1983 Aug; 75(2):321-6. PubMed ID: 6881184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin in early rheumatoid arthritis.
    Borg AA; Davis MJ; Fowler PD; Shadforth MF; Dawes PT
    Scand J Rheumatol; 1993; 22(1):39-42. PubMed ID: 8434246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
    Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
    Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
    Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters.
    Bell CL
    Am J Med; 1983 Jul; 75(1A):46-51. PubMed ID: 6346870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
    Carmichael SJ; Day RO; Tett SE
    Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood.
    Charlier B; Pingeon M; Dal Piaz F; Conti V; Valentini G; Filippelli A; Izzo V
    Biomed Chromatogr; 2018 Aug; 32(8):e4258. PubMed ID: 29669398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.
    Tett SE; Day RO; Cutler DJ
    J Rheumatol; 1993 Nov; 20(11):1874-9. PubMed ID: 8308772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of clinical assessments of disease activity in rheumatoid arthritis.
    Rhind VM; Bird HA; Wright V
    Ann Rheum Dis; 1980 Apr; 39(2):135-7. PubMed ID: 7387217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with cyclosporin switching to hydroxychloroquine in patients with rheumatoid arthritis.
    Kim WU; Seo YI; Park SH; Lee WK; Lee SK; Paek SI; Cho CS; Song HH; Kim HY
    Ann Rheum Dis; 2001 May; 60(5):514-7. PubMed ID: 11302876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.
    Porter DR; Capell HA; Hunter J
    J Rheumatol; 1993 Apr; 20(4):645-9. PubMed ID: 8496858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Hammoud HA; Aymard G; Cacoub P; Francès C; Wechsler B; Huong du LT; Ghillani P; Musset L; Lechat P; Piette JC
    Arthritis Rheum; 2006 Oct; 54(10):3284-90. PubMed ID: 17009263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids.
    Wallace DJ; Metzger AL; Stecher VJ; Turnbull BA; Kern PA
    Am J Med; 1990 Sep; 89(3):322-6. PubMed ID: 2393036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.